Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Mersana Therapeutics, Inc. (MRSN) had Current Liabilities of $63.64M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$36.85M |
|
$-171.67M |
|
-- |
|
$36.85M |
|
$216.53M |
|
$-179.67M |
|
$8.00M |
|
$-171.67M |
|
$-171.67M |
|
$-171.67M |
|
$-171.67M |
|
$-171.67M |
|
$-171.67M |
|
$-179.67M |
|
$-182.72M |
|
116.11M |
|
116.11M |
|
$-1.48 |
|
$-1.48 |
|
| Balance Sheet Financials | |
$214.06M |
|
$3.83M |
|
$12.00M |
|
$226.06M |
|
|
Current Liabilities |
$63.64M |
$23.15M |
|
$125.52M |
|
$189.16M |
|
$36.90M |
|
$36.90M |
|
$36.90M |
|
120.71M |
|
| Cash Flow Statement Financials | |
$-168.88M |
|
$119.88M |
|
$94.67M |
|
$129.36M |
|
$175.04M |
|
$45.68M |
|
$21.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
0.39 |
|
0.68 |
|
100.00% |
|
-487.51% |
|
-487.51% |
|
-495.79% |
|
-465.80% |
|
-465.80% |
|
$-171.05M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-465.18% |
|
-465.18% |
|
-75.94% |
|
-285.87% |
|
$0.31 |
|
$-1.47 |
|
$-1.45 |
|